MCID: MYP006
MIFTS: 56

Myopia malady

Categories: Genetic diseases, Eye diseases, Rare diseases

Aliases & Classifications for Myopia

About this section

Aliases & Descriptions for Myopia:

Name: Myopia 11 50 39 13 68
Myopia, Susceptibility to 27
Short-Sightedness 11
 
Near-Sightedness 11
Near Vision 11

Classifications:



External Ids:

Disease Ontology11 DOID:11830
ICD1030 H52.1
ICD9CM32 367.1
SNOMED-CT62 155133003, 57190000
MeSH39 D009216
NCIt45 C102533

Summaries for Myopia

About this section
Wikipedia:71 Near-sightedness, also known as short-sightedness and myopia, is a condition of the eye where light... more...

MalaCards based summary: Myopia, also known as myopia, susceptibility to, is related to epiphyseal dysplasia, multiple, with myopia and deafness and marshall syndrome, and has symptoms including aniseikonia and aniseikonia. An important gene associated with Myopia is SCO2 (SCO2, Cytochrome C Oxidase Assembly Protein), and among its related pathways is Degradation of the extracellular matrix. Affiliated tissues include eye, retina and endothelial, and related mouse phenotype vision/eye.

Disease Ontology:11 A refractive error characterized by the inability to see farther objects clearly.

Related Diseases for Myopia

About this section

Diseases in the Myopia family:

Myopia 14 Myopia 21, Autosomal Dominant
Myopia 8 Myopia 23, Autosomal Recessive
Myopia 9 Myopia 22, Autosomal Dominant
Myopia 10 Myopia 7
Myopia 24, Autosomal Dominant Myopia 20, Autosomal Dominant
Myopia 6 Myopia, Autosomal
Myopia 25, Autosomal Dominant

Diseases related to Myopia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 227)
idRelated DiseaseScoreTop Affiliating Genes
1epiphyseal dysplasia, multiple, with myopia and deafness33.3COL11A1, COL2A1, FMOD
2marshall syndrome32.1COL11A1, COL2A1
3deafness and myopia12.2
4degenerative myopia12.1
5myopia 612.0
6myopia 21, autosomal dominant12.0
7myopia, high, with cataract and vitreoretinal degeneration12.0
8polydactyly, postaxial, with progressive myopia12.0
9myopia 23, autosomal recessive12.0
10myopia 22, autosomal dominant12.0
11myopia 1411.9
12myopia 811.9
13myopia 911.9
14myopia 1011.9
15myopia 711.9
16myopia 20, autosomal dominant11.9
17myopia 24, autosomal dominant11.9
18myopia 25, autosomal dominant11.9
19aplasia cutis congenita, high myopia, and cone-rod dysfunction11.8
20blepharoptosis, myopia, and ectopia lentis11.8
21dandy-walker malformation with mental retardation, macrocephaly, myopia, and brachytelephalangy11.7
22spondyloepiphyseal dysplasia, myopia, and sensorineural deafness11.7
23myopia, autosomal11.7
24x-linked congenital stationary night blindness11.6
25camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye11.6
26spinocerebellar degeneration with macular corneal dystrophy, congenital cataracts, and myopia11.6
27aplasia cutis myopia11.6
28optic atrophy opthalmoplegia ptosis deafness myopia11.6
29sinus node disease and myopia11.6
30myopia, x-linked11.6
31autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome11.6
32osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome11.6
33rare isolated myopia11.6
34night blindness, congenital stationary , 1a, x-linked11.5
35bornholm eye disease11.4
36achromatopsia-311.4
37donnai-barrow syndrome11.4
38hamamy syndrome11.3
39knobloch syndrome11.3
40refractive error11.0
41anisometropia11.0
42retinitis pigmentosa10.9
43cohen syndrome10.9
44aland island eye disease10.8
45blue cone monochromacy10.8
46mousa al din al nassar syndrome10.8
47noble bass sherman syndrome10.8
48nephrotic syndrome, type 5, with or without ocular abnormalities10.7
49fibrochondrogenesis 210.7
50gyrate atrophy of choroid and retina with or without ornithinemia10.7

Graphical network of the top 20 diseases related to Myopia:



Diseases related to myopia

Symptoms & Phenotypes for Myopia

About this section

UMLS symptoms related to Myopia:


aniseikonia

MGI Mouse Phenotypes related to Myopia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053918.8COL2A1, FMOD, MYOC, NYX, PAX6, PRIMPOL

Drugs & Therapeutics for Myopia

About this section

Drugs for Myopia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 184)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RanibizumabapprovedPhase 4, Phase 3, Phase 2, Phase 1486347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
2
TropicamideapprovedPhase 4, Phase 2241508-75-45593
Synonyms:
(+-)-N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
1508-75-4
5-22-09-00359 (Beilstein Handbook Reference)
AB00052120
AC-816
AC1L1KOZ
AC1Q5IFA
AR-1K6980
Akorn Brand of Tropicamide
Alcon Brand of Tropicamide
BPBio1_000303
BRD-A79672927-001-05-8
BRN 0285563
BSPBio_000275
BSPBio_002289
Bio-0810
Bistropamide
Bournonville Brand of Tropicamide
CHEMBL1200604
CID5593
CPD000058523
Cahill May Roberts Brand of Tropicamide
Chauvin Brand of Tropicamide
Colircusi Tropicamida
D00397
D014331
DB00809
DivK1c_000448
EINECS 216-140-2
EU-0101223
Epitromina
HMS1568N17
HMS1921I09
HMS2089M05
HMS2092A18
HMS501G10
I-Picamide
I06-0811
IDI1_000448
KBio1_000448
KBio2_001064
KBio2_003632
KBio2_006200
KBio3_001509
KBioGR_000873
KBioSS_001064
L001262
LS-28545
Lopac0_001223
MLS001306442
MLS002154240
Medical Ophthalmics Brand of Tropicamide
Minims tropicamide
MolPort-000-159-321
Mydral
Mydriacyl
Mydriacyl (TN)
Mydriafair
Mydriaticum
Mydrum
N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
N-Ethyl-2-phenyl-N-4-[-pyridyl-methyl]hydracrylamide
N-Ethyl-N-(4-pyridylmethyl)tropamid
N-Ethyl-N-(4-pyridylmethyl)tropamide
N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
NCGC00016065-03
NCGC00016065-08
 
NCGC00024866-02
NCGC00024866-03
NCGC00024866-04
NCGC00024866-05
NCGC00024866-06
NINDS_000448
Novartis Brand of Tropicamide
Ocu Tropic
Ocu-Tropic
OcuTropic
Ocumed Brand of Tropicamide
Ocusoft Brand of Tropicamide
Opticyl
Paremyd
Pharmafair Brand of Tropicamide
Prestwick0_000228
Prestwick1_000228
Prestwick2_000228
Prestwick3_000228
Prestwick_487
Rivex Brand of Tropicamide
Ro 1-7683
SAM002564235
SMP1_000304
SMR000058523
SPBio_000872
SPBio_002196
SPECTRUM1500599
STK934612
Spectro-Cyl
Spectrum2_000936
Spectrum3_000655
Spectrum4_000377
Spectrum5_001585
Spectrum_000584
Stulln Brand 1 of Tropicamide
Stulln Brand 2 of Tropicamide
T 9778
T9778_SIGMA
TL8001101
Triaminic DM
Tropicacyl
Tropicamid
Tropicamida
Tropicamida [INN-Spanish]
Tropicamide
Tropicamide (JP15/USP/INN)
Tropicamide Alcon Brand
Tropicamide Chauvin Brand
Tropicamide Faure
Tropicamide Minims
Tropicamide Monofree
Tropicamide Monohydrochloride, (R)-Isomer
Tropicamide Monohydrochloride, (S)-Isomer
Tropicamide Novartis Brand
Tropicamide Ocumed Brand
Tropicamide Pharmafair Brand
Tropicamide Rivex Brand
Tropicamide [USAN:INN:BANJAN]
Tropicamide, (+-)-Isomer
Tropicamide, (R)-Isomer
Tropicamide, (S)-Isomer
Tropicamidum
Tropicamidum [INN-Latin]
Tropikamid
Tropimil
UNII-N0A3Z5XTC6
Visumidriatic
n-ethyl-n-(g-picolyl)tropamide
tropicamide
3
Atropineapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 11365908-99-6, 51-55-8174174
Synonyms:
(+,-)-Tropyl tropate
(+-)-Atropine
(+-)-Hyoscyamine
(+-)-atropine
(+-)-hyoscyamine
(+/-)-Atropine
(+/-)-Hyoscyamine
(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane
(3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(±)-atropine
(±)-hyoscyamine
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)
120-29-6
1alphaH,5alphaH-Tropan-3alpha-ol
1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)
1alphaH,5alphaH-Tropan-3beta-ol
2-Phenylhydracrylic acid 3-alpha-tropanyl ester
51-55-8
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate
A0132_SIGMA
A2468_SIGMA
AC1L5AX3
AC1Q3XL2
ACon1_000046
AI3-60219
AKOS005137976
ATROPINE
Ambap120-29-6
Anaspaz
Atropair
Atropen
Atropen (TN)
Atropin
Atropin [German]
Atropin-flexiolen
Atropina
Atropina [Italian]
Atropine
Atropine (USP)
Atropine Care
Atropine Sulfate
Atropine Sulfate S.O.P.
Atropine [BAN]
Atropinol
Atropinum
Atropt
Atrosulf
BRD-A27290375-001-01-8
Belladenal
Bellergal-S
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
C01479
C17H23NO3
CAS-120-29-6
CCRIS 3080
CHEBI:15742
CHEBI:15884
CHEBI:16684
CHEBI:537621
CHEBI:57858
CHEMBL1235490
 
CID174174
CPD001906768
Cytospaz
D00113
DB00572
DB04026
DL-Hyoscyamine
DL-Tropanyl 2-hydroxy-1-phenylpropionate
DL-Tropyl tropate
EINECS 200-104-8
Eyesules
FT-0082634
HMS2089A16
HSDB 2199
Hyoscyamine sulfate
I-Tropine
Isopto Atropine
Isopto-atropine
LS-7203
MEGxp0_001878
MLS000069795
MLS001148094
MLS002695888
Minims
Minims Atropine
MolPort-001-742-593
MolPort-003-986-158
Mydriasine
NCGC00016370-01
NCGC00142514-01
NCGC00142514-03
NP-010662
Neo-Diophen
OR22908
Ocu-Tropine
Protamine & Atropine
SAM002554885
SMR000058248
ST057178
ST057655
T0534
TL8000018
Tropanol
Tropic acid, 3-alpha-tropanyl ester
Tropic acid, ester with tropine
Tropine (+/-)-tropate
Tropine tropate
Tropine, tropate (ester)
Troyl tropate
Urised
[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
a-Tropine
atropinium cation
atropinium(1+)
b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]
beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]
bmse000649
d1-hyoscyamine
dl-Hyoscyamine
dl-Tropyltropate
dl-tropyltropate
endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
hyoscyamine
nchembio.307-comp21
tropan-3alpha-ol
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate
tropan-3beta-ol
4
OfloxacinapprovedPhase 4, Phase 1, Phase 223682419-36-14583
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
82419-36-1
83380-47-6
85344-55-4
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC-7616
AC1L1IHM
AKOS001033517
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
Bactocin
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
DB01165
DEXTROFLOXACINE
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Danoflox
DivK1c_000721
EU-0100904
Effexin
Exocin
Exocine
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
LS-133259
Liflox
Lopac0_000904
Loxinter
MLS000028749
MLS001074203
Marfloxacin
Medofloxine
Mergexin
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
 
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
NSC727071
Novecin
Nufafloqo
O 8757
O-Flox
O8757_SIGMA
OFLX
OFX
ORF 18489
ORF-28489
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
Ofloxacin (JP15/USP/INN)
Ofloxacin Otic
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
Ofus
Onexacin
Operan
Oprea1_242882
Orocin
Otonil
Oxaldin
PT 01
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
SMR000058192
SPBio_001387
SPBio_002234
SPECTRUM1502044
STK256723
Sinflo
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
Spectrum_001186
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
ofloxacin
5
Levofloxacinapproved, investigationalPhase 4, Phase 1, Phase 2236100986-85-4149096
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC-7593
AC1L3YF8
Aeroquin
Ambap100986-85-4
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
DR 3354
DR-3355
DR-3355: L-isomer of ofloxacin
DR3355
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
 
KBioGR_001605
KBioSS_002199
L-Ofloxacin
L-ofloxacin
L0193
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
LFX
LS-133260
LS-171761
LVX
Leroxacin
Lesacin
Levaquin
Levofloxacin
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
MLS000759524
MLS001165709
MLS001423977
MP-376
MolPort-002-885-835
Mosardal
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Oftaquix
Quixin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
Reskuin
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Spectrum_001719
Tavanic
Volequin
d-Levofloxacin
6
DipivefrinapprovedPhase 49752365-63-63105
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
52365-63-6
AB00514686
AC1L1F6K
AKOS003662293
AKPro
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D02349
DB00449
Dipivalyl Epinephrine
 
Dipivefrin
Dipivefrin (USAN)
Dipivefrin HCL
Dipivefrin [USAN]
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipivéfrine
K 30081
L000915
LS-121419
NCGC00179499-01
Ophtho-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Pro-Epinephrine
Propine
Propine C Cap B.I.D.
SPBio_002843
UNII-8Q1PVL543G
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
dipivalyl epinephrine
dipivefrin
nchembio747-comp3
7
KetorolacapprovedPhase 432374103-06-3, 66635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
8
Verteporfinapproved, investigationalPhase 4, Phase 3, Phase 190129497-78-5
Synonyms:
Verteporfin
 
Verteporfina
Verteporfinum
Vertéporfine
9
NepafenacapprovedPhase 44278281-72-8151075
Synonyms:
2-amino-3-Benzoylbenzeneacetamide
AHR 9434
AHR-9434
AL 6515
 
AL-6515
Amfenac amide
Nepafenaco
Nepafenacum
Nevanac
10
Bevacizumabapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 12020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
11
Povidone-iodineapprovedPhase 416925655-41-8
Synonyms:
 
Betadine
12
FluorometholoneapprovedPhase 420426-13-19878
Synonyms:
(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11beta,17alpha-Dihydroxy-9-fluoro-6-methyl-1,4-pregnadiene-3,20-dione
426-13-1
9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
AC-3520
AC1L1U0Y
AI3-52813
Alcon Brand of Fluorometholone
Allergan Brand 1 of Fluorometholone
Allergan Brand 2 of Fluorometholone
Allergan Brand 3 of Fluorometholone
BPBio1_001029
BRD-K64862097-001-03-9
BSPBio_000935
CHEMBL1200600
CID9878
Cortilet
Cortisdin
D005469
D01367
DB00324
Delmeson
EINECS 207-041-5
Efflumidex
F0414
F9381_SIGMA
FML
FML Forte
FML Liquifilm
FML S.O.P
FML-S Liquifilm
Fluaton
Flucon
Flucon, Isopto
Flumetholon
Fluor Op
Fluor-OP
Fluor-Op
Fluor-op (TN)
Fluormetholon
Fluormetholone
Fluormetholonum
Fluoro Ophtal
Fluoro-Ophtal
Fluoromethalone
Fluorometholon
Fluorometholone
 
Fluorometholone (JP15/USP/INN)
Fluorometholone [INN:BAN:JAN]
Fluorometholonum
Fluorometholonum [INN-Latin]
Fluorometolona
Fluorometolona [INN-Spanish]
Fluorometolone
Fluorometolone [DCIT]
Fluorométholone
Fluoropos
Fml (TN)
HMS1570O17
Isdin Brand of Fluorometholone
Isopto Flucon
LS-118455
Loticort
MLS000069537
MLS001076157
MolPort-003-941-413
NCGC00021575-03
NCI60_002886
NSC 33001
NSC-33001
NSC33001
Neo-Oxylone
Novartis Brand of Fluorometholone
Oxylone
Oxylone (TN)
PMS Fluorometholone
PMS-Fluorometholone
Pharm Allergan Brand of Fluorometholone
Pharm-Allergan Brand of Fluorometholone
Pharmascience Brand of Fluorometholone
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl- (8CI)
Prestwick0_000718
Prestwick1_000718
Prestwick2_000718
Prestwick3_000718
Prestwick_227
SMR000058598
SPBio_002856
Trilcin
U 8614
UNII-SV0CSG527L
Ursapharm Brand of Fluorometholone
Ursnon
Winzer Brand of Fluorometholone
ZINC03876158
component of Neo-Oxylone
fluorometholone
13
LoteprednolapprovedPhase 45382034-46-6, 129260-79-3444025, 9865442
Synonyms:
82034-46-6
AC1L9FKJ
AKOS005145741
Alrex
Alrex, Lotemax, Loteprednol etabonate
CDDD-5604
CHEBI:31784
CHEMBL1200865
CID444025
CPD000469178
D01689
DB00873
HGP-1
HMS2051F16
IDR-90102
IDR-90103
Locort
 
Loteflam
Lotemax
Lotemax (TN)
Loteprednol
Loteprednol Etabonate
Loteprednol etabonate
Loteprednol etabonate (JAN/USAN)
Loteprednolum
Loterox
MLS001424221
MolPort-003-848-424
NCGC00164594-01
P-5604
S1669_Selleck
SAM001246630
SMR000469178
ZINC03920673
chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
chloromethyl 17alpha-[(ethoxycarbonyl)oxy]-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate
14
Bromfenacapproved, Approved July 1997Phase 44391714-94-260726
Synonyms:
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid
2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
2-amino-3-(4-Bromobenzoyl)benzeneacetic acid
91714-94-2
AC1L1TSW
AC1Q5DQ7
AHR-10282
Ambap120638-55-3
BROMFENAC SODIUM
Bromfenac
Bromfenac (INN)
Bromfenac [INN]
Bromfenac sodium
Bromfenaco
Bromfenaco [Spanish]
 
Bromfenacum
Bromfenacum [Latin]
C15H12BrNO3
CHEBI:240107
CHEMBL1077
CID60726
D07541
DB00963
Duract
LS-178156
MolPort-000-883-091
UNII-864P0921DW
Xibrom
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate
{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
15glucocorticoidsPhase 4, Phase 3, Phase 1, Phase 25103
16Hormone AntagonistsPhase 4, Phase 3, Phase 1, Phase 213180
17Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 1, Phase 213168
18MydriaticsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 1811
19Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 1, Phase 210729
20Bronchodilator AgentsPhase 4, Phase 2, Phase 3, Phase 12965
21Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 3, Phase 13093
22AnestheticsPhase 4, Phase 2, Phase 3, Phase 19596
23Anti-Asthmatic AgentsPhase 4, Phase 2, Phase 3, Phase 13488
24Anti-Infective AgentsPhase 4, Phase 1, Phase 222062
25TetrahydrozolinePhase 4, Phase 2, Phase 3, Phase 1621
26Autonomic AgentsPhase 4, Phase 2, Phase 3, Phase 110150
27Ophthalmic SolutionsPhase 4, Phase 2, Phase 3, Phase 11140
28HormonesPhase 4, Phase 3, Phase 1, Phase 214415
29Adjuvants, AnesthesiaPhase 4, Phase 2, Phase 3, Phase 11674
30Angiogenesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 14257
31Muscarinic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11166
32Neurotransmitter AgentsPhase 4, Phase 2, Phase 3, Phase 118340
33Respiratory System AgentsPhase 4, Phase 2, Phase 3, Phase 14997
34ParasympatholyticsPhase 4, Phase 2, Phase 3, Phase 11085
35Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 123689
36Angiogenesis Modulating AgentsPhase 4, Phase 3, Phase 2, Phase 14185
37MitomycinsPhase 4, Phase 1240
38Nucleic Acid Synthesis InhibitorsPhase 4, Phase 14962
39Cholinergic AgentsPhase 4, Phase 2, Phase 3, Phase 13992
40Cholinergic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11706
41Antibiotics, AntitubercularPhase 4, Phase 1, Phase 27180
42Alkylating AgentsPhase 4, Phase 14827
43Anti-Bacterial AgentsPhase 4, Phase 1, Phase 211226
44Photosensitizing AgentsPhase 4, Phase 3, Phase 1492
45Dermatologic AgentsPhase 4, Phase 3, Phase 15806
46Trace ElementsPhase 46001
47MicronutrientsPhase 46001
48Gastrointestinal AgentsPhase 48402
49Anti-Infective Agents, LocalPhase 4, Phase 21880
50Adrenergic AgentsPhase 4, Phase 35352

Interventional clinical trials:

(show top 50)    (show all 572)
idNameStatusNCT IDPhase
1Study of Myopia Prevention in Children With Low Concentration of AtropineUnknown statusNCT00541177Phase 4
2Ranibizumab for Myopic NeovascularizationUnknown statusNCT01246089Phase 4
3Aflibercept Intravitreal Injection for Myopic Choroidal NeovascularizationUnknown statusNCT02033018Phase 4
4A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIKUnknown statusNCT01977807Phase 4
5Multi Laser Platform Comparison Study for LASIKUnknown statusNCT00770094Phase 4
6A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIKUnknown statusNCT02071576Phase 4
7A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and PresbyopiaUnknown statusNCT02112968Phase 4
8Clinical Investigation of the Bi Flex M Multifocal IOLUnknown statusNCT02338882Phase 4
9Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 SecondsCompletedNCT00564213Phase 4
10Visual Outcomes and Contrast Sensitivity After Myopic LASIKCompletedNCT01746589Phase 4
11A Comparison of PRK and LASIK for Correction of MyopiaCompletedNCT00404105Phase 4
12An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic PatientsCompletedNCT01173198Phase 4
13Bevacizumab Intravitreal for Myopic Choroidal NeovascularizationCompletedNCT00797992Phase 4
14Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens ExtractionCompletedNCT01225952Phase 4
15Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic EyesCompletedNCT01387360Phase 4
16Evaluation of the Post-LASIK Flap Thickness of the FS200 Femtosecond Laser FlapCompletedNCT01693939Phase 4
17Contralateral Comparison of Three Excimer Laser Systems in Performing LASIKCompletedNCT00821236Phase 4
18Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are RefitCompletedNCT02588573Phase 4
19BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover StudyCompletedNCT02537730Phase 4
20Clinical Evaluation of Daily Disposable Contact LensesCompletedNCT02097030Phase 4
21Daily Disposable Comparison StudyCompletedNCT02094677Phase 4
22Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue MoistCompletedNCT02024698Phase 4
23Evaluation of Stenfilcon A Versus Etafilcon ACompletedNCT01809834Phase 4
24Clinical Performance of Stenfilcon A Versus Filcon II 3CompletedNCT01808209Phase 4
25Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact LensesCompletedNCT01707238Phase 4
26Evaluation of Comfilcon A and Senofilcon A LensesCompletedNCT01695369Phase 4
27Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive KeratectomyCompletedNCT01475877Phase 4
28Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIKCompletedNCT00889941Phase 4
29Comparative Performance of PureVision, Acuvue Oasys and O2OptixCompletedNCT00640341Phase 4
30Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of VisionCompletedNCT00627302Phase 4
31Long-term Effects of Laser Refractive SurgeryCompletedNCT00350246Phase 4
32Effects of Contact Lens Care Regimens on the Corneal EpitheliumCompletedNCT00349882Phase 4
33Investigation of Multi-Purpose Solution-Based Corneal Staining and Ocular ComfortCompletedNCT00349843Phase 4
34Daily Wear Corneal Infiltrative Event StudyCompletedNCT00937105Phase 4
35Visual Performance After RESTOR ImplantationCompletedNCT01065064Phase 4
36Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular SurfaceCompletedNCT01250925Phase 4
37Corneal and Conjunctival Sensitivity and Staining StudyCompletedNCT00455455Phase 4
38Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRKCompletedNCT00347204Phase 4
39Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).CompletedNCT00620893Phase 4
40Evaluation of 3 Intraocular Lenses Following Lens ExtractionCompletedNCT01122576Phase 4
41PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal NeovascularizationCompletedNCT00358345Phase 4
42Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular LensesCompletedNCT02985723Phase 4
43Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL)CompletedNCT01210807Phase 4
44Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLsCompletedNCT00366587Phase 4
45Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision MultifocalCompletedNCT01591499Phase 4
46Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover TrialRecruitingNCT02186184Phase 4
47Comparison of Next Generation Laser Techniques of Myopia Correction: iDesign vs. SMILERecruitingNCT03001401Phase 4
48A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.RecruitingNCT03101501Phase 4
49A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before ImplantationRecruitingNCT03126877Phase 4
50Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal NeovascularizationRecruitingNCT03042871Phase 4

Search NIH Clinical Center for Myopia


Cochrane evidence based reviews: myopia

Genetic Tests for Myopia

About this section

Genetic tests related to Myopia:

id Genetic test Affiliating Genes
1 Myopia27

Anatomical Context for Myopia

About this section

MalaCards organs/tissues related to Myopia:

36
Eye, Retina, Endothelial, Testes, Heart, Cortex, Liver

Publications for Myopia

About this section

Articles related to Myopia:

(show top 50)    (show all 1021)
idTitleAuthorsYear
1
Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression. (28063778)
2017
2
Evaluation of Therapeutic Tissue Crosslinking (TXL) for Myopia Using Second Harmonic Generation Signal Microscopy in Rabbit Sclera. (28055099)
2017
3
Evaluation of genome-wide susceptibility loci for high myopia in a Han Chinese population. (28085524)
2017
4
The role of microRNAs in myopia. (27837278)
2017
5
Mutations in DZIP1 and XYLT1 are associated with nonsyndromic early onset high myopia in the Korean population. (28085539)
2017
6
A Prospective Study to Compare Visual Outcomes Between Wavefront-optimized and Topography-guided Ablation Profiles in Contralateral Eyes With Myopia. (28068440)
2017
7
Update on Orthokeratology in Managing Progressive Myopia in Children: Efficacy, Mechanisms, and Concerns. (28092397)
2017
8
Effects of Background Lighting Color and Movement Distance on Reaching Times Among Participants With Low Vision, Myopia, and Normal Vision. (27166331)
2016
9
Effectiveness of Toric Orthokeratology in the Treatment of Patients with Combined Myopia and Astigmatism. (27980362)
2016
10
Different roles of retinal dopamine in albino Guinea pig myopia. (28041966)
2016
11
Childhood gene-environment interactions and age-dependent effects of genetic variants associated with refractive error and myopia: The CREAM Consortium. (27174397)
2016
12
Pseudoduplication of the optic disc in moderate myopia. (28003787)
2016
13
Education-Related Parameters in High Myopia: Adults versus School Children. (27152764)
2016
14
A control-matched comparison of flap off and flap on laser-assisted subepithelial keratectomy (LASEK) for the treatment of myopia and myopic astigmatism. (26949353)
2016
15
Identifying Children at Risk of High Myopia Using Population Centile Curves of Refraction. (28030593)
2016
16
Combined Special Capsular Tension Ring and Toric IOL Implantation for Management of Astigmatism and High Axial Myopia with Cataracts. (28005433)
2016
17
Inverted Internal Limiting Membrane Insertion for Macular Hole-Associated Retinal Detachment in High Myopia. (27174666)
2016
18
Early outcomes after small incision lenticule extraction and photorefractive keratectomy for correction of high myopia. (27601090)
2016
19
Posterior chamber collagen copolymer phakic intraocular lens with a central hole for moderate-to-high myopia: First experience in China. (27603356)
2016
20
Refractive Outcome of Cataract Surgery in Eyes With Prior Trabeculectomy: Risk Factors for Postoperative Myopia. (27661991)
2016
21
Eye exercises of acupoints: their impact on myopia and visual symptoms in Chinese rural children. (27599547)
2016
22
Re: Chia etA al.: Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9). (27210609)
2016
23
Single-step transepithelial photorefractive keratectomy in myopia and astigmatism: 18-month follow-up. (27956283)
2016
24
Application of optical coherence tomography angiography in assessment of posterior scleral reinforcement for pathologic myopia. (28003976)
2016
25
Long-Term Observation of Triplex Surgery for Cataract after Phakic 6H Implantation for Super High Myopia. (27190642)
2016
26
Association between Ocular Axial Length-Related Genes and High Myopia in a Han Chinese Population. (26485405)
2016
27
Long-term Results of Small-incision Lenticule Extraction in High Myopia. (28058160)
2016
28
Large-Scale microRNA Expression Profiling Identifies Putative Retinal miRNA-mRNA Signaling Pathways Underlying Form-Deprivation Myopia in Mice. (27622715)
2016
29
Association between SCO2 mutation and extreme myopia in Japanese patients. (27052445)
2016
30
Abnormal pigment epithelium-derived factor processing in progressive myopia. (27590659)
2016
31
Accommodative spasm might influence surgical planning and outcomes in acute acquired distance esotropia in myopia. (27515204)
2016
32
Myopia Development Among Young Schoolchildren: The Myopia Investigation Study in Taipei. (28002845)
2016
33
Effects of carbomer eye drops in combination with orthokeratology lens in treating adolescent myopia. (28078849)
2016
34
Corneal Curvature Radius in Myopia of Schoolchildren Versus Adult Myopia. (27100659)
2016
35
Controversial opinion: evaluation of EGR1 and LAMA2 loci for high myopia in Chinese populations. (26984843)
2016
36
Comparison of Several Parameters in Two Optical Coherence Tomography Systems for Detecting Glaucomatous Defects in High Myopia. (27654417)
2016
37
Visual and Refractive Outcomes of Photorefractive Keratectomy and Small Incision Lenticule Extraction (SMILE) for Myopia. (27598730)
2016
38
Viscoat Assisted Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes Associated with High Myopia. (27047686)
2016
39
Posterior scleral reinforcement for the treatment of pathological myopia. (27162733)
2016
40
The investigation on the role of mitochondrial fusion protein 1 in the development of myopia. (27609161)
2016
41
Methodology and Myopia? Some Praise, a Problem, and a Plea. (27649832)
2016
42
Association of COL1A1 polymorphism with high myopia: a Meta-analysis. (27162737)
2016
43
EPIDEMIC OF PATHOLOGIC MYOPIA: What Can Laboratory Studies and Epidemiology Tell Us? (27617538)
2016
44
GORE-TEX VASCULAR GRAFT FOR MACULAR BUCKLING IN HIGH MYOPIA EYES. (27984549)
2016
45
Clinical Characterization of LRPAP1-Related Pediatric High Myopia. (26271838)
2016
46
Association of Insulin-Like Growth Factor-1 Gene Polymorphisms with Different Types of Myopia in Egyptian Patients. (27167306)
2016
47
Dry Eye after Small Incision Lenticule Extraction (SMILE) versus Femtosecond Laser-Assisted in Situ Keratomileusis (FS-LASIK) for Myopia: A Meta-Analysis. (27992482)
2016
48
Exome sequencing identified null mutations in LOXL3 associated with early-onset high myopia. (26957899)
2016
49
Early changes to dry eye and ocular surface after small-incision lenticule extraction for myopia. (27162732)
2016
50
ISMP Adverse Drug Reactions: Sildenafil-Induced Erythema Multiforme Acute Liver Injury Due to Febuxostat Intravenous Acetaminophen-Induced Acute Hepatotoxicity Acute Transient Myopia Induced by Zanamivir Lidocaine-Induced Hoigne Syndrome. (28057946)
2016

Variations for Myopia

About this section

Expression for genes affiliated with Myopia

About this section
Search GEO for disease gene expression data for Myopia.

Pathways for genes affiliated with Myopia

About this section

Pathways related to Myopia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.1COL11A1, COL2A1, FBN1, FMOD, P3H2, P4HA2

GO Terms for genes affiliated with Myopia

About this section

Cellular components related to Myopia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1basement membraneGO:000560410.5COL2A1, FBN1, P3H2
2endoplasmic reticulum lumenGO:000578810.1COL11A1, COL2A1, FBN1, P3H2, P4HA2
3extracellular matrixGO:00310129.7ADAMTS17, COL11A1, COL2A1, FBN1, FMOD, MYOC
4proteinaceous extracellular matrixGO:00055788.8ADAMTS17, COL11A1, COL2A1, FBN1, FMOD, MYOC

Biological processes related to Myopia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1cartilage condensationGO:000150210.8COL11A1, COL2A1
2proteoglycan metabolic processGO:000602910.7COL11A1, COL2A1
3peptidyl-proline hydroxylationGO:001951110.7P3H2, P4HA2
4eye developmentGO:000165410.5PAX6, SCO2, SLC39A5
5inner ear morphogenesisGO:004247210.5COL11A1, COL2A1, SLITRK6
6sensory perception of soundGO:000760510.5COL11A1, COL2A1, SLITRK6
7collagen fibril organizationGO:003019910.5COL11A1, COL2A1, FMOD
8camera-type eye developmentGO:004301010.4FBN1, PAX6, SLITRK6
9axonogenesisGO:000740910.4FMOD, PAX6, SLITRK6
10visual perceptionGO:00076019.1COL11A1, COL2A1, NYX, PAX6, RDH8, SLITRK6

Molecular functions related to Myopia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrix structural constituentGO:000520110.2COL11A1, COL2A1, FBN1
2L-ascorbic acid bindingGO:003141810.0P3H2, P4HA2

Sources for Myopia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet